$BCLI - another biotech buyout for gene therapy for a space with unmet need.  the company that&#39;s being bought is double in shares outstanding (45M) when compared to BCLI. company is being bought for $3B or $60/share. 

https://www.businesswire.com/news/home/20191202005969/en/
<ticker> - another biotech buyout for gene therapy for a space with unmet need . the company that is being bought is double in shares outstanding <number> m when compared to bcli . company is being bought for $ <number> b or $ <number> / share .